BioXcel Therapeutics (Nasdaq: BTAI) retweeted
Dr. Vince O’Neill of @BioXcel_Tx discusses safety and tolerability results from a phase 1b study testing BXCL701, a novel inhibitor of DPP8/9 / FAP, in combination with pembrolizumab in small cell/ neuroendocrine #ProstateCancer. #PCFRetreat19
BioXcel Therapeutics (Nasdaq: BTAI) retweeted
We're celebrating another milestone @BioXcel_Tx! The grand opening of our new office space in #NewHaven! Our CEO details his vision and the use of #AI and #MachineLearning in drug development with @NewHavenBiz.
newhavenbiz.com/article/biox…
BioXcel Therapeutics (Nasdaq: BTAI) retweeted
POSITIVE RESULTS FROM BXCL501 TRIAL OFFERS HOPE TO PATIENTS WITH SCHIZOPHRENIA RELATED AGITATION
aviseanalytics.com/positive-… #OTC $BTAI $ALNY $AXLA $TAK #NASDAQ #artificialintelligence #behavioraldisorders #bipolardisorder #FDA #schizophrenia #technology #healthcare #innovations
BioXcel Therapeutics (Nasdaq: BTAI) retweeted
.@SapnaSyngal of @DanaFarber discusses the new @NCCNnews Guidelines which stress #GeneticTesting in #PancreaticCancer patients. Dr. Syngal is part of the @lustgartenfdn @SU2C interception team. #gencsm https://teapaw.org/t.co/vl3jFunpBT
BioXcel Therapeutics (Nasdaq: BTAI) retweeted
⚡️CEO Spotlight⚡️
👤 @BioXcel_Tx CEO Vimal Mehta chats with @NPetallides about the company’s role in #AI #drug development. Full interview on #TheWatchList:
BioXcel Therapeutics (Nasdaq: BTAI) retweeted
Some new mothers used to leave hospitals with opioid prescriptions no matter what. Now hospitals are revisiting how they offer painkillers, @rddysum reports. wsj.com/articles/the-push-fo…
BioXcel Therapeutics (Nasdaq: BTAI) retweeted
Highlight: @BioXcel_Tx’s Dr. Vimal Mehta on the company’s new drug called BXCL501: “You put it under the tongue, it has a rapid onset of action and then it starts calming the patient [down]… This is the first drug came from the use of our artificial intelligence platform.”
Video
Powered by SnappyTV
BioXcel Therapeutics (Nasdaq: BTAI) retweeted
Can a robot named Milo reach children in autism in ways humans can’t? Some schools think so, @rddysum writes wsj.com/articles/robots-take…
BioXcel Therapeutics (Nasdaq: BTAI) retweeted
A study by Dr. Gloria Petersen's research team at the @MayoClinic helped contribute to official recommendations from the @NCCNnews and @ASCO that all #PancreaticCancer patients receive genetic testing. https://teapaw.org/t.co/6IudOBZX7W
BioXcel Therapeutics (Nasdaq: BTAI) retweeted
With summer right around the corner, we are taking this #MelanomaMonday to raise awareness about #malignant #melanoma - the most dangerous type of skin #cancer. The easiest way to prevent melanoma is #sunscreen!
BioXcel Therapeutics (Nasdaq: BTAI) retweeted
States are cutting retiree health benefits as a way of dealing with mounting liabilities and balancing budgets wsj.com/articles/as-retiree-…
BioXcel Therapeutics (Nasdaq: BTAI) retweeted
Interesting read in @WSJ. Scientists use #AI implants to decode the brain's electric signals and use a speech synthesizer to turn it into words, allowing people with impaired abilities to speak.
#Healthcare #Innovation #Robotics #Augmentation #Future #ML
on.wsj.com/2PvryfX
BioXcel Therapeutics (Nasdaq: BTAI) retweeted
According to @business, Connecticut is the 4th most innovative state in the nation. We are extremely proud to be part of a community that is helping build a brighter future.
#Innovation #Technology #Community #Future
@BioCT_org @CT_Innovate
bloom.bg/2W5TJ7F
BioXcel Therapeutics (Nasdaq: BTAI) retweeted
Can #AI solve its own problems? https://teapaw.org/t.co/QHwywxvsbc
#ArtificialIntelligence #MachineLearning #Innovation #Future #IoT
Via @TDataScience
BioXcel Therapeutics (Nasdaq: BTAI) retweeted
Team InveniAI was honored to be a part of the 7th International Conference on Rare and Undiagnosed Diseases to discuss the application of #AI to advance treatment options for #RareDiseases. #RNUD2019 #Healthcare
BioXcel Therapeutics (Nasdaq: BTAI) retweeted
A study by Dr. Gloria Petersen's research team at the @MayoClinic helped contribute to official recommendations from the @NCCNnews and @ASCO that all #PancreaticCancer patients receive genetic testing. https://teapaw.org/t.co/6IudOBZX7W
BioXcel Therapeutics (Nasdaq: BTAI) retweeted
Wasting, or cachexia, is the focus of a #ClinicalTrial at @CedarsSinai testing a cachexia immunotherapy treatment combined with standard #PancreaticCancer treatment. https://teapaw.org/t.co/dKybhV6rSR
BioXcel Therapeutics (Nasdaq: BTAI) retweeted
Africa's cities — and their 2.5 billion people — will be facing a water crisis by 2050
BioXcel Therapeutics (Nasdaq: BTAI) retweeted
#ArtificialIntelligence, #MachineLearning, and #DeepLearning are all considered siblings under the #DataScience umbrella. Although the terminologies are usually used interchangeably, they are not quite the same thing. #NationalSiblingDay #WednesdayWisdom https://teapaw.org/t.co/Q3hflMsD1M
BioXcel Therapeutics (Nasdaq: BTAI) retweeted
Join our President and CEO, Krishnan Nandabalan, this afternoon at 2:20 pm EST to learn about how #AI and #ML can de-risk drug development for #RareDiseases. #WODCUSA














